Cytokinetics | CYTK - Cost Of Sales



Cytokinetics reported 112.55M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Acadia Pharmaceuticals USD 20.73M 342K Jun/2025
Amgen USD 3.01B 406M Jun/2025
Bayer EUR 4.36B 1.26B Jun/2025
Biogen USD 605M 24.3M Jun/2025
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Cytokinetics 112.55M 12.71M Jun/2025
Eisai JPY 42.6B 2B Jun/2025
Eli Lilly USD 2.45B 223.6M Jun/2025
Exelixis USD 19.47M 298K Jul/2025
Geron 1.19M 16K Jun/2025
Halozyme Therapeutics USD 64.12M 15.72M Jun/2025
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
Ligand Pharmaceuticals USD 11.16M 6.32M Jun/2025
Merck USD 2.82B 53M Jun/2025
Novartis USD 3.32B 95M Jun/2025
Pfizer USD 4.99B 2.4B Jun/2025
Regeneron Pharmaceuticals USD 530.2M 264.7M Jun/2025
Roche Holding CHF 4.13B 393.5M Dec/2024
Sanofi EUR 2.99B 103M Jun/2025